Dr. Mark J. Stavas
Claim this profileSoutheast Nebraska Cancer Center - 68th Street Place
Area of expertise
Breast Cancer
Mark J. Stavas has run 2 trials for Breast Cancer. Some of their research focus areas include:
Prostate Cancer
Mark J. Stavas has run 1 trial for Prostate Cancer.
Affiliated Hospitals
Southeast Nebraska Cancer Center - 68th Street Place
Cancer Partners Of Nebraska - Pine Lake
Clinical Trials Mark J. Stavas is currently running
Apalutamide + Hormone and Radiation Therapies
for Prostate Cancer
This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.
Recruiting
2 awards
Phase 3
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting
2 awards
Phase 3
15 criteria
More about Mark J. Stavas
Clinical Trial Related
6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Mark J. Stavas has experience with
- Apalutamide
- Ipilimumab
- Nivolumab
- Radiation Therapy
- 3-Dimensional Conformal Radiation Therapy
- Atezolizumab
Breakdown of trials Mark J. Stavas has run
Breast Cancer
Prostate Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark J. Stavas specialize in?
Mark J. Stavas focuses on Breast Cancer and Prostate Cancer. In particular, much of their work with Breast Cancer has involved HER2 positive patients, or patients who are ER positive.
Is Mark J. Stavas currently recruiting for clinical trials?
Yes, Mark J. Stavas is currently recruiting for 3 clinical trials in Lincoln Nebraska. If you're interested in participating, you should apply.
Are there any treatments that Mark J. Stavas has studied deeply?
Yes, Mark J. Stavas has studied treatments such as Apalutamide, Ipilimumab, Nivolumab.
What is the best way to schedule an appointment with Mark J. Stavas?
Apply for one of the trials that Mark J. Stavas is conducting.
What is the office address of Mark J. Stavas?
The office of Mark J. Stavas is located at: Southeast Nebraska Cancer Center - 68th Street Place, Lincoln, Nebraska 68516 United States. This is the address for their practice at the Southeast Nebraska Cancer Center - 68th Street Place.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.